11.3 Acute Diabetic & Metabolic Crises: DKA, HHS & Severe Hypoglycemia

Acute Diabetic & Metabolic Crises: DKA, HHS & Severe Hypoglycemia

Clinical Core: Acute metabolic derangements in diabetes mellitus represent high-acuity medical emergencies requiring meticulous fluid, electrolyte, and hormone management. While Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) share common ground in hyperglycemia and osmotic diuresis, their underlying hormonal landscapes, fluid deficits, and biochemical disturbances differ markedly. Concurrently, severe hypoglycemia poses an immediate threat of irreversible neuroglycopenic neuronal death. The registered nurse must master emergency fluid resuscitation algorithms, enforce rigorous potassium safety gates before insulin delivery, and prevent cerebral edema during glycemic stabilization.

---

Pathophysiology & Differential Diagnosis: DKA vs. HHS

Hormonal Mechanisms and Ketogenesis

• Diabetic Ketoacidosis (DKA): Driven by an absolute insulin deficiency combined with marked counter-regulatory hormone excess (glucagon, catecholamines, cortisol, growth hormone). This occurs predominantly in Type 1 Diabetes Mellitus, often precipitated by infection, omitted insulin, acute trauma, or myocardial infarction. In the absolute absence of insulin, tissues cannot take up glucose, prompting massive peripheral lipolysis via hormone-sensitive lipase. Uncontrolled lipolysis floods the liver with free fatty acids, which undergo hepatic $\beta$-oxidation into acidic ketone bodies (acetoacetate and $\beta$-hydroxybutyrate). The accumulation of ketoacids overwhelms blood buffer systems, producing a high anion gap metabolic acidosis, compensatory hyperventilation (Kussmaul respirations to blow off volatile carbonic acid), sweet fruity/acetone breath odor, abdominal pain, nausea, and vomiting.
• Hyperosmolar Hyperglycemic State (HHS): Driven by a relative insulin deficiency combined with inadequate fluid intake. This occurs predominantly in older adults with Type 2 Diabetes Mellitus, often triggered by severe infections (pneumonia, urinary sepsis), stroke, glucocorticoid therapy, or acute coronary syndrome. In HHS, the concentration of endogenous insulin is sufficient to suppress adipose lipolysis and prevent hepatic ketogenesis, but insufficient to facilitate peripheral glucose clearance or inhibit hepatic gluconeogenesis. Blood glucose rises unchecked to extreme levels ($>600\text{ to }1,200\text{ mg/dL}$), causing profound plasma hyperosmolality ($>320\text{ mOsm/kg}$), severe glucosuria, massive osmotic diuresis, and staggering fluid losses (8 to 10+ liters). The clinical picture is dominated by severe dehydration, hypovolemia, lethargy, stupor, focal neurological deficits, and coma without prominent ketoacidosis.

Clinical and Laboratory Differentiation Table

---

Evidence-Based Nursing Management: The Four Core Pillars

Pillar 1: Aggressive Intravenous Fluid Resuscitation

Fluid replacement takes precedence over insulin administration. Rehydration expands effective circulating plasma volume, restores renal perfusion, enhances urinary excretion of excess glucose, and reduces circulating counter-regulatory hormone levels.

1. Hour 1 (Immediate Volume Expansion): In severe hypovolaemia, give 0.9% sodium chloride (or another isotonic crystalloid) at about 1 L/h. Then aim to replace about half the estimated deficit over 8–12 hours (2024 consensus), watching closely for fluid overload in older or cardiac clients.
2. Subsequent Hours (Cellular Hydration): Evaluate the client's corrected serum sodium, because hyperglycemia draws intracellular water into the vascular space, causing pseudohyponatremia: $\text{Corrected } [Na^+] = \text{Measured } [Na^+] + 1.6 \times \left( \frac{\text{Glucose} - 100}{100} \right)$
   • If corrected sodium is normal or high ($\ge 135\text{ mEq/L}$): Infuse 0.45% Normal Saline at 250 to 500 mL/hr to provide hypotonic fluid for intracellular hydration.
   • If corrected sodium is low ($<135\text{ mEq/L}$): Continue 0.9% Normal Saline at 250 to 500 mL/hr.
3. The Critical Glycemic Transition Point (Preventing Cerebral Edema):
   • When plasma glucose falls below $250\text{ mg/dL}$ (13.9 mmol/L), add 5% or 10% dextrose to the IV fluids and reduce the insulin infusion to about 0.05 units/kg/h. Keep glucose at about 150–200 mg/dL in DKA (200–250 mg/dL in HHS) until the crisis resolves (2024 consensus). Older protocols switched at 200 mg/dL in DKA and 300 mg/dL in HHS.
   • Pathophysiological Rationale: Brain cells produce intracellular idiogenic osmoles to maintain cell volume in hyperosmolar states. If extracellular plasma osmolality collapses rapidly due to plunging blood glucose while brain cells remain hyperosmolar, a steep osmotic gradient forms that draws water into cerebral astrocytes, provoking life-threatening cerebral edema (manifesting as acute headache, lethargy, bradycardia, confusion, and papilledema). Adding dextrose prevents rapid osmolar collapse and hypoglycemia while permitting uninterrupted IV insulin infusion to clear ketoacids.

Pillar 2: The Potassium Safety Gate (Non-Negotiable Resuscitation Rule)

During acute DKA and HHS, clients suffer massive total-body potassium depletion from osmotic diuresis and urinary potassium wasting. However, baseline serum potassium may appear falsely normal or elevated due to extracellular shifts driven by acidosis, hyperosmolality, and insulin lack.

• SAFETY RULE: Delay insulin if serum potassium is $<3.5\text{ mmol/L}$ (2024 consensus; the 2009 guidance used 3.3), and replace potassium first.
• Biological Danger: Insulin binds to cell surface receptors, stimulating $Na^+/K^+$ ATPase pumps that drive potassium rapidly from the extracellular fluid into the intracellular space. Rehydration and correction of acidosis also push potassium intracellularly. Administering insulin to a client with pre-existing hypokalemia causes serum potassium to collapse, triggering lethal ventricular dysrhythmias (ventricular fibrillation, torsades de pointes, asystole) and diaphragmatic respiratory arrest.
• Potassium Management Algorithm:
  • If Serum $K^+ < 3.5\text{ mmol/L}$: Hold insulin. Give IV potassium chloride at about 10–20 mmol/h until potassium is above 3.5 mmol/L, then start insulin. Faster replacement needs central access and cardiac monitoring.
  • If Serum $K^+$ is $3.5\text{ to }5.0\text{ mmol/L}$: Start insulin and add 10–20 mmol of KCl to each litre of IV fluid, keeping potassium between 4.0 and 5.0 mmol/L.
  • If Serum $K^+ > 5.0\text{ mmol/L}$: Give no potassium. Start insulin and fluids, and recheck potassium every 2 hours.

Pillar 3: Continuous Intravenous Regular Insulin Infusion

• Insulin Formulation: Only Regular Insulin (short-acting) can be administered intravenously.
• Infusion Dosing: Give a fixed-rate IV infusion of regular insulin at 0.1 units/kg/h in moderate or severe DKA. A 0.1 units/kg IV bolus may be given if setting up the infusion is delayed. Use 0.05 units/kg/h in HHS without significant ketosis.
• Target Glycemic Rate of Decline: Adjust the insulin infusion to achieve a safe, steady decline in blood glucose of 50 to 75 mg/dL per hour (2.8 to 4.2 mmol/L/hr).
  • If glucose drops faster than 75 to 100 mg/dL/hr, reduce insulin rate or increase dextrose concentration to avert cerebral edema.
  • If glucose fails to decline by at least 50 mg/dL in the first hour, verify IV patency and fluid hydration; if hydration is adequate, double the insulin infusion rate.
• Resolution Criteria (2024 consensus):
  • DKA is resolved when plasma ketones (beta-hydroxybutyrate) are below 0.6 mmol/L and venous pH is 7.3 or more or bicarbonate is 18 mmol/L or more.
  • HHS is resolved when calculated osmolality is below 300 mOsm/kg, urine output exceeds 0.5 mL/kg/h, cognition has improved and glucose is below 250 mg/dL.
• The Subcutaneous Transition Bridge: Do not discontinue the IV insulin infusion until the client is awake, alert, tolerating oral food, and a dose of subcutaneous basal insulin (e.g., glargine or detemir) has been administered 1 to 2 hours prior to stopping the IV infusion. Because IV regular insulin has an ultra-short half-life (approx. 5 to 9 minutes), discontinuing the drip without prior basal insulin coverage causes rapid rebound hyperglycemia and recurrence of ketoacidosis.

Pillar 4: Acid-Base & Bicarbonate Restrictions

• Routine sodium bicarbonate administration is strictly avoided in DKA. Clinical trials confirm that bicarbonate therapy fails to improve morbidity or mortality and causes significant harm: paradoxical intracellular central nervous system acidosis (exogenous bicarbonate converts to $CO_2$, which freely crosses the blood-brain barrier while bicarbonate cannot), acute hypocalcemia, severe hypokalemia, and delayed clearance of blood ketoacids.
• Exception: The 2024 consensus says bicarbonate may be considered only if pH is below 7.0. The dose is 100 mmol of 8.4% sodium bicarbonate in 400 mL sterile water, repeated every 2 hours until pH exceeds 7.0.

---

Severe Hypoglycemia: Emergency Recognition & Tiered Protocols

Hypoglycemia is defined as a blood glucose level $<70\text{ mg/dL}$ (3.9 mmol/L). Severe, clinically significant hypoglycemia is defined as $<54\text{ mg/dL}$ (3.0 mmol/L) or any episode producing severe cognitive impairment, seizures, or coma requiring external intervention.

Symptom Spectrum: Neurogenic vs. Neuroglycopenic

• Neurogenic (Autonomic Warning Signs): Triggered by sympathoadrenal activation releasing epinephrine and norepinephrine: diaphoresis, tremors, tachycardia, palpitations, pallor, anxiety, tingling, and hunger. Clinical Pearl: Clients on non-selective beta-blockers (e.g., propranolol) or with chronic diabetic autonomic neuropathy experience hypoglycemia unawareness; beta-blockers mask adrenergic signs (tachycardia, palpitations, tremors), leaving diaphoresis as the primary observable clue.
• Neuroglycopenic (Cerebral Glucose Starvation Signs): Triggered by inadequate neuronal glucose delivery: confusion, irrational behavior, irritability, slurred speech, ataxia, diplopia, drowsiness, focal neurological deficits (mimicking stroke), seizures, coma, and brain death.

Tiered Emergency Management Protocols

                                  ACUTE HYPOGLYCEMIA (< 70 mg/dL or symptomatic)
                                                        |
                       +--------------------------------+--------------------------------+
                       |                                                                 |
           CONSCIOUS & ABLE TO SWALLOW                                       UNCONSCIOUS, OBTUNDED, OR NPO
                       |                                                                 |
                 RULE OF 15                                               ESTABLISH AIRWAY / LATERAL POSITION
                       |                                                                 |
   Administer 15-20 g Fast-Acting Simple Carbs                     +---------------------+---------------------+
   - 4 oz (120 mL) Fruit Juice or Regular Soda                     |                                           |
   - 3-4 Glucose Tablets or 1 Tube Glucose Gel            IV ACCESS PRESENT                           NO IV ACCESS
   (Avoid high-fat milk or chocolate)                              |                                           |
                       |                                 Administer 25-50 mL of D50W              Administer Glucagon 1 mg
           Wait 15 Minutes & Retest Glucose               Slow IV Push over 2-3 min               IM or SC Injection
                       |                                 (Confirm patent large-bore IV;          (Turn client on side;
         +-------------+-------------+                    extravasation vesicant risk)            emesis upon waking)
         |                           |                                 |                                       |
   Glucose < 70 mg/dL          Glucose >= 70 mg/dL                     +-------------------+-------------------+
         |                           |                                                     |
   Repeat 15 g Simple          Provide Complex Carb + Protein                  Wait 15 Minutes & Retest Glucose
   Carbohydrate Bolus          Snack (Crackers + Peanut Butter)                            |
                               if next meal is > 1 hour away                   If Glucose < 70 mg/dL: Repeat Dose

• Conscious Client (The Rule of 15):
  1. Administer 15 to 20 grams of rapid-acting simple carbohydrate: 4 ounces (120 mL) of fruit juice or regular soda, 3 to 4 glucose tablets, or 1 tube of oral glucose gel.
  2. Avoid complex carbohydrates or high-fat foods (e.g., chocolate bars, ice cream, whole milk); fat delays gastric emptying and slows intestinal glucose absorption.
  3. Re-test capillary blood glucose in 15 minutes.
  4. If blood glucose remains $<70\text{ mg/dL}$, repeat 15 grams of simple carbohydrates.
  5. Once blood glucose normalizes ($\ge 70\text{ mg/dL}$), administer a snack containing complex carbohydrates and protein (e.g., peanut butter crackers, half a sandwich) if the next meal is $>1\text{ hour}$ away.
• Unconscious, Obtunded, or NPO Client:
  • Airway & Positioning: Maintain airway patency; place the client in the lateral recovery position to prevent aspiration.
  • IV Access Present: Administer 25 to 50 mL of 50% Dextrose in Water (D50W) slow IV push over 2 to 3 minutes.
    • Nursing Safety Warning: D50W is an extreme hypertonic vesicant ($\approx 2,525\text{ mOsm/L}$). Confirm blood return from a patent, large-bore IV prior to administration; extravasation causes chemical cellulitis, tissue necrosis, and skin ulceration.
  • No IV Access: Administer Glucagon 1 mg intramuscularly (IM) or subcutaneously (SC) (or 3 mg intranasal glucagon powder).
    • Clinical Caveat: Glucagon stimulates hepatic glycogenolysis; it is ineffective in clients with depleted hepatic glycogen reserves (e.g., severe malnutrition, chronic alcoholism, prolonged fasting). Position the client on their side, as glucagon commonly provokes nausea and vomiting upon awakening.